Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#2 clBTC clBTC +12.08%
#3 Tutorial Tutorial +6.71%
#4 Palladium Network Palladium Network +6.69%
#5 OpenEden OpenEden +6.37%
#6 EfficientFrontier EfficientFrontier +5.09%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +4.66%
#8 Momentum Momentum +4.55%
#9 Prom Prom +3.88%
#10 Bedrock Bedrock +3.76%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
BioSyntech, Inc. BioSyntech, Inc.

BioSyntech, Inc.

BSYI
Rang in Aktien #40152
BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels... BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing chronic wounds; BST-Ossifil, used in bone void filling; BST-Ossifix, which provides structural support for bones; and BST-Disc, focused on restoring intervertebral discs. Beyond these, BioSyntech offers injectable products leveraging BST-Gel technology to precisely deliver biotherapeutics. Its technological assets also include Arthro-BST, an arthroscopic device for the non-destructive evaluation of cartilage degradation or repair, and Mach-1, a micromechanical testing system for assessing the properties of various tissues and materials. The company also manufactures ultra-pure chitosans under the Ultrasan brand and offers both manufacturing and analytical services. Founded in 1994 and based in Laval, Canada, BioSyntech Inc. initiated administration proceedings under the Bankruptcy and Insolvency Act on May 12, 2010, and is currently undergoing reorganization.
Aktienkurs
$0.00001
Zuletzt synchronisiert: 2025-09-24
Marktkapitalisierung
$229.03K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel BioSyntech, Inc. (BSYI)

Kategorie

Healthcare
Preis BSYI mit Marktkapitalisierung von B
BioSyntech, Inc. BioSyntech, Inc.
BSYI
$0.00001
Marktkapitalisierung von BioSyntech, Inc.(BSYI)
Marktkapitalisierung: $229.03K
Mit Stand August 2026 hat BioSyntech, Inc. eine Marktkapitalisierung von $229.03K. Das macht BioSyntech, Inc. laut unseren Daten zum 40152nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von BioSyntech, Inc. von 2000 bis 2026
BSYI im Vergleich zu den Top 5 der beliebtesten stocks
Preis für BSYI Vermögenswert B Marktkapitalisierung von B Ergebnisse
BioSyntech, Inc. BioSyntech, Inc.
$238.81 $229.03K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +2,388,100,207.82%
BioSyntech, Inc. BioSyntech, Inc.
$195.04 $229.03K
Apple Inc. Apple Inc.
AAPL
$4.467T +1,950,404,952.23%
BioSyntech, Inc. BioSyntech, Inc.
$182.26 $229.03K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +1,822,613,395.18%
BioSyntech, Inc. BioSyntech, Inc.
$161.55 $229.03K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +1,615,521,379.22%
BioSyntech, Inc. BioSyntech, Inc.
$124.63 $229.03K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +1,246,258,168.24%